A detailed history of Encompass Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Encompass Wealth Advisors, LLC holds 1,605 shares of LLY stock, worth $1.33 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,605
Holding current value
$1.33 Million
% of portfolio
0.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$727.2 - $932.06 $1.17 Million - $1.5 Million
1,605 New
1,605 $1.24 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $1.48 Million - $1.98 Million
2,502 New
2,502 $1.95 Million
Q1 2021

May 25, 2021

SELL
$164.32 - $212.72 $67,206 - $87,002
-409 Closed
0 $0
Q4 2020

Mar 09, 2021

BUY
$130.46 - $172.63 $53,358 - $70,605
409 New
409 $69,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Encompass Wealth Advisors, LLC Portfolio

Follow Encompass Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Encompass Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Encompass Wealth Advisors, LLC with notifications on news.